Skip to main content
×
×
Home

Curcumin and cognition: a randomised, placebo-controlled, double-blind study of community-dwelling older adults

  • Stephanie R. Rainey-Smith (a1) (a2), Belinda M. Brown (a1) (a2), Hamid R. Sohrabi (a1) (a2) (a3), Tejal Shah (a1) (a2), Kathryn G. Goozee (a3) (a4), Veer B. Gupta (a1) (a2) and Ralph N. Martins (a1) (a2) (a3)...
Abstract

Curcumin therapy in animals has produced positive cognitive and behavioural outcomes; results of human trials, however, have been inconsistent. In this study, we report the results of a 12-month, randomised, placebo-controlled, double-blind study that investigated the ability of a curcumin formulation to prevent cognitive decline in a population of community-dwelling older adults. Individuals (n 96) ingested either placebo or 1500 mg/d BiocurcumaxTM for 12 months. A battery of clinical and cognitive measures was administered at baseline and at the 6-month and 12-month follow-up assessments. A significant time×treatment group interaction was observed for the Montreal Cognitive Assessment (repeated-measures analysis; time×treatment; F=3·85, P<0·05). Subsequent analysis revealed that this association was driven by a decline in function of the placebo group at 6 months that was not observed in the curcumin treatment group. No differences were observed between the groups for all other clinical and cognitive measures. Our findings suggest that further longitudinal assessment is required to investigate changes in cognitive outcome measures, ideally in conjunction with biological markers of neurodegeneration.

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Curcumin and cognition: a randomised, placebo-controlled, double-blind study of community-dwelling older adults
      Available formats
      ×
      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Curcumin and cognition: a randomised, placebo-controlled, double-blind study of community-dwelling older adults
      Available formats
      ×
      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Curcumin and cognition: a randomised, placebo-controlled, double-blind study of community-dwelling older adults
      Available formats
      ×
Copyright
Corresponding author
* Corresponding author: Professor R. N. Martins, fax +61 8 9347 4299, email ralph.n.martins@gmail.com
References
Hide All
1. Zhang, C, Browne, A, Child, D, et al. (2010) Curcumin decreases amyloid-beta peptide levels by attenuating the maturation of amyloid-beta precursor protein. J Biol Chem 285, 2847228480.
2. Sikora, E, Scapagnini, G & Barbagallo, M (2010) Curcumin, inflammation, ageing and age-related diseases. Immun Ageing 7, 1.
3. Yadav, B, Taurin, S, Rosengren, RJ, et al. (2010) Synthesis and cytotoxic potential of heterocyclic cyclohexanone analogues of curcumin. Bioorg Med Chem 18, 67016707.
4. Sikora, E, Bielak-Zmijewska, A, Mosieniak, G, et al. (2010) The promise of slow down ageing may come from curcumin. Curr Pharm Des 16, 884892.
5. Aggarwal, BB, Sundaram, C, Malani, N, et al. (2007) Curcumin: the Indian solid gold. Adv Exp Med Biol 595, 175.
6. Mutsuga, M, Chambers, JK, Uchida, K, et al. (2012) Binding of curcumin to senile plaques and cerebral amyloid angiopathy in the aged brain of various animals and to neurofibrillary tangles in Alzheimer’s brain. J Vet Med Sci 74, 5157.
7. Ma, QL, Zuo, X, Yang, F, et al. (2013) Curcumin suppresses soluble tau dimers and corrects molecular chaperone, synaptic, and behavioral deficits in aged human tau transgenic mice. J Biol Chem 288, 40564065.
8. Garcia-Alloza, M, Borrelli, LA, Rozkalne, A, et al. (2007) Curcumin labels amyloid pathology in vivo, disrupts existing plaques, and partially restores distorted neurites in an Alzheimer mouse model. J Neurochem 102, 10951104.
9. Huang, HC, Chang, P, Dai, XL, et al. (2012) Protective effects of curcumin on amyloid-beta-induced neuronal oxidative damage. Neurochem Res 37, 15841597.
10. Masters, CL, Simms, G, Weinman, NA, et al. (1985) Amyloid plaque core protein in Alzheimer disease and down syndrome. Proc Natl Acad Sci U S A 82, 42454249.
11. Kosik, KS, Joachim, CL & Selkoe, DJ (1986) Microtubule-associated protein tau (tau) is a major antigenic component of paired helical filaments in Alzheimer disease. Proc Natl Acad Sci U S A 83, 40444048.
12. Zotova, E, Nicoll, JA, Kalaria, R, et al. (2010) Inflammation in Alzheimer’s disease: relevance to pathogenesis and therapy. Alzheimers Res Ther 2, 1.
13. Akiyama, H, Barger, S, Barnum, S, et al. (2000) Inflammation and Alzheimer’s disease. Neurobiol Aging 21, 383421.
14. Agostinho, P, Cunha, RA & Oliveira, C (2010) Neuroinflammation, oxidative stress and the pathogenesis of Alzheimer’s disease. Curr Pharm Des 16, 27662778.
15. Mithu, VS, Sarkar, B, Bhowmik, D, et al. (2014) Curcumin alters the salt bridge-containing turn region in amyloid beta(1-42) aggregates. J Biol Chem 289, 1112211131.
16. Lim, GP, Chu, T, Yang, F, et al. (2001) The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse. J Neurosci 21, 83708377.
17. Yang, F, Lim, GP, Begum, AN, et al. (2005) Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo . J Biol Chem 280, 58925901.
18. Wang, YJ, Thomas, P, Zhong, JH, et al. (2009) Consumption of grape seed extract prevents amyloid-beta deposition and attenuates inflammation in brain of an Alzheimer’s disease mouse. Neurotox Res 15, 314.
19. Ma, QL, Yang, F, Rosario, ER, et al. (2009) Beta-amyloid oligomers induce phosphorylation of tau and inactivation of insulin receptor substrate via c-Jun N-terminal kinase signaling: suppression by omega-3 fatty acids and curcumin. J Neurosci 29, 90789089.
20. Frautschy, SA, Hu, W, Kim, P, et al. (2001) Phenolic anti-inflammatory antioxidant reversal of A-beta induced cognitive deficits and neuropathology. Neurobiol Aging 22, 9911003.
21. Ng, TP, Chiam, PC, Lee, T, et al. (2006) Curry consumption and cognitive function in the elderly. Am J Epidemiol 164, 898906.
22. Baum, L, Lam, CW, Cheung, SK, et al. (2008) Six-month randomized, placebo-controlled, double-blind, pilot clinical trial of curcumin in patients with Alzheimer disease. J Clin Psychopharmacol 28, 110113.
23. Ringman, JM, Frautschy, SA, Teng, E, et al. (2012) Oral curcumin for Alzheimer’s disease: tolerability and efficacy in a 24-week randomized, double blind, placebo-controlled study. Alzheimers Res Ther 4, 43.
24. Cox, KH, Pipingas, A & Scholey, AB (2015) Investigation of the effects of solid lipid curcumin on cognition and mood in a healthy older population. J Psychopharmacol 29, 642651.
25. Gota, VS, Maru, GB, Soni, TG, et al. (2010) Safety and pharmacokinetics of a solid lipid curcumin particle formulation in osteosarcoma patients and healthy volunteers. J Agric Food Chem 58, 20952099.
26. DiSilvestro, RA, Joseph, E, Zhao, S, et al. (2012) Diverse effects of a low dose supplement of lipidated curcumin in healthy middle aged people. Nutr J 11, 79.
27. Villemagne, VL, Burnham, S, Bourgeat, P, et al. (2013) Amyloid beta deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer’s disease: a prospective cohort study. Lancet Neurol 12, 357367.
28. Antony, B, Merina, B, Iyer, VS, et al. (2008) A pilot cross-over study to evaluate human oral bioavailability of BCM-95CG (Biocurcumax), a novel bioenhanced preparation of curcumin. Indian J Pharm Sci 70, 445449.
29. Ware, JE Jr & Sherbourne, CD (1992) The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 30, 473483.
30. Rossetti, HC, Lacritz, LH, Cullum, CM, et al. (2011) Normative data for the Montreal Cognitive Assessment (MoCA) in a population-based sample. Neurology 77, 12721275.
31. American Psychiatric Association (2000) Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Washington, DC: APA.
32. Lovibond, SH & Lovibond, PF (1993) Manual for the Depression Anxiety Stress Scales (DASS), Australia Psychology Foundation Monograph. Sydney: Psychology Foundation.
33. Beardsall, L (1998) Development of the Cambridge Contextual Reading Test for improving the estimation of premorbid verbal intelligence in older persons with dementia. Br J Clin Psychol 37, 229240.
34. Lovibond, PF & Lovibond, SH (1995) The structure of negative emotional states: comparison of the Depression Anxiety Stress Scales (DASS) with the Beck Depression and Anxiety Inventories. Behav Res Ther 33, 335343.
35. Smith, G, Della Sala, S, Logie, RH, et al. (2000) Prospective and retrospective memory in normal ageing and dementia: a questionnaire study. Memory 8, 311321.
36. Nasreddine, ZS, Phillips, NA, Bedirian, V, et al. (2005) The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 53, 695699.
37. Spreen, O & Strauss, E (1998) A Compendium of Neuropsychological Tests. Administration, Norms, and Commentary. New York: Oxford University Press.
38. Lezak, MD, Howieson, DB & Loring, DW (2004) Neuropsychological Assessment. New York: Oxford University Press.
39. Wechsler, D (1981) Wechsler Adult Intelligence Scale-Revised (WAIS-R). New York: Psychological Corporation.
40. Agrawal, R, Mishra, B, Tyagi, E, et al. (2010) Effect of curcumin on brain insulin receptors and memory functions in STZ (ICV) induced dementia model of rat. Pharmacol Res 61, 247252.
41. Dong, S, Zeng, Q, Mitchell, ES, et al. (2012) Curcumin enhances neurogenesis and cognition in aged rats: implications for transcriptional interactions related to growth and synaptic plasticity. PLOS ONE 7, e31211.
42. Yu, SY, Zhang, M, Luo, J, et al. (2013) Curcumin ameliorates memory deficits via neuronal nitric oxide synthase in aged mice. Prog Neuropsychopharmacol Biol Psychiatry 45, 4753.
43. Maruff, P, Collie, A, Darby, D, et al. (2004) Subtle memory decline over 12 months in mild cognitive impairment. Dement Geriatr Cogn Disord 18, 342348.
44. Bergman, J, Miodownik, C, Bersudsky, Y, et al. (2013) Curcumin as an add-on to antidepressive treatment: a randomized, double-blind, placebo-controlled, pilot clinical study. Clin Neuropharmacol 36, 7377.
45. Lopresti, AL, Maes, M, Maker, GL, et al. (2014) Curcumin for the treatment of major depression: a randomised, double-blind, placebo controlled study. J Affect Disord 167, 368375.
46. Sanmukhani, J, Satodia, V, Trivedi, J, et al. (2014) Efficacy and safety of curcumin in major depressive disorder: a randomized controlled trial. Phytother Res 28, 579585.
47. Kulkarni, SK, Bhutani, MK & Bishnoi, M (2008) Antidepressant activity of curcumin: involvement of serotonin and dopamine system. Psychopharmacology (Berl) 201, 435442.
48. Huang, Z, Zhong, XM, Li, ZY, et al. (2011) Curcumin reverses corticosterone-induced depressive-like behavior and decrease in brain BDNF levels in rats. Neurosci Lett 493, 145148.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

British Journal of Nutrition
  • ISSN: 0007-1145
  • EISSN: 1475-2662
  • URL: /core/journals/british-journal-of-nutrition
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Keywords

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed